Suppr超能文献

人类免疫细胞对不同异种和同种去细胞化生物材料的反应。

Human immune-cell response towards diverse xenogeneic and allogeneic decellularized biomaterials.

机构信息

Department of Surgery, Medical University of Vienna, Austria.

Surgical Research Laboratories, Medical University of Vienna, Austria.

出版信息

Int J Surg. 2016 Dec;36(Pt A):347-351. doi: 10.1016/j.ijsu.2016.06.042. Epub 2016 Jun 27.

Abstract

BACKGROUND

Immunological knowledge on processed biological implants and mesh-prostheses is still mainly based on animal models, lacking information on the species-specific human immune response. We hypothesized that in contrast to human tissue even decellularized xenogenic specimens would lead to significant and tissue source dependent human immune reactions.

METHODS

Specimens from processed allogenic and xenogenic pulmonary arteries, pericardium or dermis, were co-cultured with human peripheral blood mononuclear cells (PBMNC). Proliferative responses were measured in tritiated thymidine incorporation assays (n = 10). Stimulation indices (SI), calculated as counts-per-minute of co-cultured PBMNC divided by the cpm of basic cell proliferation, were compared.

RESULTS

Compared to native porcine pulmonary artery tissue decellularization significantly reduced human PBMNC proliferation (mean SI: 48.7 vs. 18.0, p < 0.01), which was still higher compared to the human equivalent (SI: 0.7 vs. 1.7). Also the processed human dermal implant did not elicit immune response (SI: 1.5), whereas the decellularized and cross-linked porcine dermis lead to a significant human cell-proliferation (SI: 8.4, p < 0.01). Interestingly, both the processed human (SI: 15.2) and bovine pericardial patches (SI: 15.1) led to higher immune cell proliferation.

CONCLUSION

Even decellularized or cross-linked xenogenic cardiovascular and reconstructive biomaterials elicit increased human immune responses not seen in the majority of allogenic specimens tested.

摘要

背景

关于加工生物植入物和网片假体的免疫学知识主要仍基于动物模型,缺乏关于种属特异性人类免疫反应的信息。我们假设,与人体组织相比,即使去细胞化的异种标本也会导致明显的、依赖组织来源的人类免疫反应。

方法

将加工的同种异体和异种肺动脉、心包或真皮标本与人类外周血单核细胞(PBMNC)共培养。通过氚标记胸腺嘧啶掺入测定(n=10)测量增殖反应。计算刺激指数(SI),即共培养的 PBMNC 的每分钟计数除以基础细胞增殖的 cpm,进行比较。

结果

与天然猪肺动脉组织相比,去细胞化显著降低了人类 PBMNC 的增殖(平均 SI:48.7 对 18.0,p<0.01),与人类等效物(SI:0.7 对 1.7)相比仍然更高。加工的人真皮植入物也没有引起免疫反应(SI:1.5),而去细胞化和交联的猪真皮则导致明显的人类细胞增殖(SI:8.4,p<0.01)。有趣的是,加工的人(SI:15.2)和牛心包补片(SI:15.1)都导致更高的免疫细胞增殖。

结论

即使是去细胞化或交联的异种心血管和重建生物材料也会引起增加的人类免疫反应,而在大多数测试的同种异体标本中没有观察到这种反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验